FDA Immediately Approves Drug That’s Doubling Lifespan for Late Pancreatic Cancer Patients.

Pancreatic cancer has long been a death sentence, and a rapid one at that, but a new two-a-day pill has seen patients live twice as long even after chemotherapy fails, according to Good News Network.